{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:11:46Z","timestamp":1790284306122,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY02162"],"award-info":[{"award-number":["EY02162"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY029703"],"award-info":[{"award-number":["EY029703"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.exer.2024.109793","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T11:53:52Z","timestamp":1705665232000},"page":"109793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Permanent transduction of retinal ganglion cells by rAAV2-retro"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1399-434X","authenticated-orcid":false,"given":"Yicen J.","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikayla D.","family":"Dilbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Economides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2024.109793_bib1","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1111\/ejn.15027","article-title":"Comparative analyses of transgene expression patterns after intra-striatal injections of rAAV2-retro in rats and rhesus monkeys: a light and electron microscopic study","volume":"52","author":"Albaugh","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.exer.2024.109793_bib2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1073\/pnas.58.4.1410","article-title":"Isolation of adenovirus-associated viruses from man","volume":"58","author":"Blacklow","year":"1967","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exer.2024.109793_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/hum.2016.085","article-title":"Highly efficient delivery of adeno-associated viral vectors to the primate retina","volume":"27","author":"Boye","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2024.109793_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors - implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2024.109793_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0014-4835(86)90026-6","article-title":"Acute reversible cataract induced by xylazine and by ketamine-xylazine anesthesia in rats and mice","volume":"42","author":"Calderone","year":"1986","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2024.109793_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.spen.2017.06.001","article-title":"Dominant optic atrophy and leber's hereditary optic neuropathy: update on clinical features and current therapeutic approaches","volume":"24","author":"Chun","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.exer.2024.109793_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108859","article-title":"Using rAAV2-retro in rhesus macaques: promise and caveats for circuit manipulation","volume":"345","author":"Cushnie","year":"2020","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.exer.2024.109793_bib8","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1167\/iovs.16-19701","article-title":"A novel method combining vitreous aspiration and intravitreal AAV2\/8 injection results in retina-wide transduction in adult mice","volume":"57","author":"Da Costa","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109793_bib9","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/S0042-6989(98)00308-3","article-title":"Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV","volume":"39","author":"Dudus","year":"1999","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2024.109793_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4939-9139-6_14","article-title":"SubILM injection of AAV for gene delivery to the retina","volume":"1950","author":"Gamlin","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exer.2024.109793_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/genes12020147","article-title":"From transcriptomics to treatment in inherited optic neuropathies","volume":"12","author":"Gilhooley","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.exer.2024.109793_bib12","first-page":"949","article-title":"Anesthetic-induced corneal lesions in developmentally sensitive rats","volume":"29","author":"Guillet","year":"1988","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109793_bib13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","article-title":"Gene therapy for leber hereditary optic neuropathy: low- and medium-dose visual results","volume":"124","author":"Guy","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2024.109793_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1167\/iovs.13-13365","article-title":"Retinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy","volume":"55","author":"Guy","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109793_bib15","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6317","article-title":"Evaluation of AAV-DJ vector for retinal gene therapy","volume":"7","author":"Katada","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.exer.2024.109793_bib16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ncomms1145","article-title":"Herpesviruses carrying a Brainbow cassette reveal replication and expression of limited numbers of incoming genomes","volume":"1","author":"Kobiler","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2024.109793_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132804","article-title":"Ketamine\/xylazine-Induced corneal damage in mice","volume":"10","author":"Koehn","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2024.109793_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamaophthalmol.2013.7630","article-title":"Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial","volume":"132","author":"Koilkonda","year":"2014","journal-title":"JAMA ophthalmology"},{"key":"10.1016\/j.exer.2024.109793_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/gt.2014.115","article-title":"Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates","volume":"22","author":"Kotterman","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.exer.2024.109793_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ajo.2022.02.023","article-title":"Leber hereditary optic neuropathy gene therapy: adverse events and visual acuity results of all patient groups","volume":"241","author":"Lam","year":"2022","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2024.109793_bib21","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1167\/iovs.15-18862","article-title":"In vivo fluorescence retinal imaging following AAV2-mediated gene delivery in the rat retina","volume":"57","author":"Lee","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109793_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0006-8993(83)90371-2","article-title":"Massive retinotectal projection in rats","volume":"272","author":"Linden","year":"1983","journal-title":"Brain Res."},{"key":"10.1016\/j.exer.2024.109793_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exer.2024.109793_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41434-021-00272-8","article-title":"Novel tool to quantify with single-cell resolution the number of incoming AAV genomes co-expressed in the mouse nervous system","volume":"30","author":"Maturana","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.exer.2024.109793_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109084","article-title":"Fundus imaging of retinal ganglion cells transduced by retrograde transport of rAAV2-retro","volume":"219","author":"Nanjappa","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2024.109793_bib26","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and safety of intravitreal gene therapy for leber hereditary optic neuropathy treated within 6 Months of disease onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2024.109793_bib27","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awac421","article-title":"Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy","volume":"146","author":"Newman","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.exer.2024.109793_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/02713683.2019.1565890","article-title":"Morphology and composition of the inner limiting membrane: species-specific variations and relevance toward drug delivery Research","volume":"44","author":"Peynshaert","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2024.109793_bib29","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1089\/hum.2022.138","article-title":"Immune responses and immunosuppressive strategies for adeno-associated virus-based gene therapy for treatment of central nervous system disorders: current knowledge and approaches","volume":"33","author":"Prasad","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2024.109793_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/02713683.2013.845224","article-title":"Effects of three commonly used anesthetics on intraocular pressure in mouse","volume":"39","author":"Qiu","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2024.109793_bib31","first-page":"74","article-title":"Persistent expression of dopamine-synthesizing enzymes 15 Years after gene transfer in a primate model of Parkinson's disease. Human gene therapy","volume":"28","author":"Sehara","year":"2017","journal-title":"Clinical development"},{"key":"10.1016\/j.exer.2024.109793_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108258","article-title":"Translatability barriers between preclinical and clinical trials of AAV gene therapy in inherited retinal diseases","volume":"210","author":"Shamshad","year":"2023","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2024.109793_bib33","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1056\/NEJM198905183202002","article-title":"A mitochondrial DNA mutation as a cause of Leber's hereditary optic neuropathy","volume":"320","author":"Singh","year":"1989","journal-title":"NEJM"},{"key":"10.1016\/j.exer.2024.109793_bib34","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/s41598-018-19969-9","article-title":"In vivo imaging of adeno-associated viral vector labelled retinal ganglion cells","volume":"8","author":"Smith","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2024.109793_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/laban0608-247","article-title":"Exophthalmos in rats. Anesthesia-induced exophthalmos","volume":"37","author":"Smith","year":"2008","journal-title":"Lab. Anim."},{"key":"10.1016\/j.exer.2024.109793_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113205","article-title":"Solutions to a radical problem: overview of current and future treatment strategies in leber's hereditary opic neuropathy","volume":"23","author":"Spiegel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2024.109793_bib37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/mt.2008.283","article-title":"Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates","volume":"17","author":"Stieger","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2024.109793_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ymthe.2016.10.008","article-title":"Improved intravitreal AAV-mediated inner retinal gene transduction after surgical internal limiting membrane peeling in cynomolgus monkeys","volume":"25","author":"Takahashi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2024.109793_bib39","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1167\/iovs.18-24333","article-title":"Surgical removal of internal limiting membrane and layering of AAV vector on the retina under air enhances gene transfection in a nonhuman primate","volume":"59","author":"Teo","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109793_bib40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","article-title":"A designer AAV variant permits efficient retrograde access to projection neurons","volume":"92","author":"Tervo","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.exer.2024.109793_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000055692","article-title":"Corneal toxicity of xylazine and clonidine, in combination with ketamine, in the rat","volume":"33","author":"Tita","year":"2001","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2024.109793_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1167\/iovs.62.2.41","article-title":"Characterization of gene therapy associated uveitis following intravitreal adeno-associated virus injection in mice","volume":"62","author":"Tummala","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109793_bib43","first-page":"175","article-title":"Susceptibility of rats to corneal lesions after injectable anesthesia","volume":"55","author":"Turner","year":"2005","journal-title":"Comp. Med."},{"key":"10.1016\/j.exer.2024.109793_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.exer.2024.109793_bib45","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1038\/s41598-020-63559-7","article-title":"Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic development","volume":"10","author":"Weiss","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2024.109793_bib46","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1167\/iovs.10-6250","article-title":"Intravitreal injection of AAV2 transduces macaque inner retina","volume":"52","author":"Yin","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2024.109793_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483524000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T15:15:44Z","timestamp":1719674144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483524000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"alternative-id":["S0014483524000149"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2024.109793","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Permanent transduction of retinal ganglion cells by rAAV2-retro","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2024.109793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109793"}}